Skip to main content
. Author manuscript; available in PMC: 2011 Nov 14.
Published in final edited form as: Appl Immunohistochem Mol Morphol. 2010 Jul;18(4):375–381. doi: 10.1097/PAI.0b013e3181d6bd59

Table 1.

Distribution of HIF-1α, PHD2/3 expressions studied by double immunostaining methods in formalin/parrafin sections of surgical biopsies from oropharyngeal SCC cases.

HIF-1α positive cases

Number of cases Histology HIF-1α PHD2 PHD3 Difference in PHD2 and/or 3 expression between HIF-1α positive and negative tumor cells
1 1 PD 2 m-s/10 s/100 m/30 no difference
2 WD w-s/20 s/100 m/30 PHD3 is lower
3 WD s/20 m/100 m/30 no difference
4 PD s/10 s/100 m-s/90 PHD3 is lower
5 WD m-s/80 w/100 s/10 PHD3 is lower
6 PD s/30 w/100 m-s/80 no difference

HIF-1α negative cases

7 WD nd w/100 m-s/40
8 WD nd w-m/100 m-s/40
9 WD nd w/100 m-s/80
10 PD nd s/100 m-s/10
11 PD nd s/100 s/70
12 WD nd m-s/100 m-s/50
13 PD nd s/100 s/100
14 WD nd w-m/100 m-s/30
15 PD nd m-s/100 s/40
1

PD: poorly differentiated WD: well differentiated

2

Immunostaining: s:strong, m:moderate, w:weak, nd:not detectable

Numbers after the symbols indicate the estimated percentage of immunostained tumor cells.